-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Adhera Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2012 to 2022.
- Adhera Therapeutics, Inc. General and Administrative Expense for the quarter ending September 30, 2023 was $43K, a 80.8% decline year-over-year.
- Adhera Therapeutics, Inc. General and Administrative Expense for the twelve months ending September 30, 2023 was $1.38M, a 21.2% increase year-over-year.
- Adhera Therapeutics, Inc. annual General and Administrative Expense for 2022 was $1.62M, a 146% increase from 2021.
- Adhera Therapeutics, Inc. annual General and Administrative Expense for 2021 was $657K, a 45.2% decline from 2020.
- Adhera Therapeutics, Inc. annual General and Administrative Expense for 2020 was $1.2M, a 74.6% decline from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)